SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-07-080729
Filing Date
2007-11-07
Accepted
2007-11-07 16:37:58
Documents
6
Period of Report
2007-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q a07-25414_110q.htm 10-Q 766159
2 EX-10.43 a07-25414_1ex10d43.htm EX-10.43 26250
3 EX-10.44 a07-25414_1ex10d44.htm EX-10.44 360827
4 EX-31.1 a07-25414_1ex31d1.htm EX-31.1 11256
5 EX-31.2 a07-25414_1ex31d2.htm EX-31.2 11778
6 EX-32 a07-25414_1ex32.htm EX-32 11561
  Complete submission text file 0001104659-07-080729.txt   1189316
Mailing Address 901 GATEWAY BLVD S. SAN FRANCISCO CA 94080
Business Address 901 GATEWAY BLVD SOUTH SAN FRANCISCO CA 94080 6508086000
THERAVANCE INC (Filer) CIK: 0001080014 (see all company filings)

IRS No.: 943265960 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-30319 | Film No.: 071221973
SIC: 2834 Pharmaceutical Preparations